ARUP's Laboratory Test Directory

JAK2 Gene, V617F Mutation, Qualitative : 0051245
[ image for: Additional Technical Information]
Additional Technical Information
  


Mnemonic: JAK2

Ordering Recommendation: Aids in the workup of suspected myeloproliferative neoplasms. Detects the JAK2 V617F mutation in peripheral blood or bone marrow.
Methodology: Polymerase Chain Reaction
Performed: Sun-Sat
Reported: 2-7 days
Specimen Required: Collect: Lavender (EDTA) OR bone marrow (EDTA).

Specimen Preparation: Do not freeze. Transport 5 mL whole blood (Min: 1 mL) OR 3 mL bone marrow (Min: 1 mL)..

Storage/Transport Temperature: Refrigerated.

Unacceptable Conditions: Serum. Specimens collected in anticoagulants other than EDTA. Frozen specimens. Clotted or grossly hemolyzed specimens.

Stability (collection to initiation of testing): Ambient: 24 hours; Refrigerated: 5 days; Frozen: Unacceptable
Reference Interval:
By report
Interpretive Data: Refer to report.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration, however, FDA clearance or approval is not currently required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

See Compliance Statement B: www.aruplab.com/CS
CPT Code(s): 81270, G0452
Cross References: Tyrosine Kinase Mutation (JAK2 Gene, V617F Mutation, Qualitative)